Insights in Stem Cells Open Access

  • Journal h-index: 3
  • Journal CiteScore: 0.19
  • Journal Impact Factor: 0.12
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Reach us +32 25889658

Editorial - (2015) Volume 1, Issue 1

Insight in Stem Cell

Kouichi Hasegawa*

Senior Lecturer, Institute for Integrated Cell-Material Science (iCeMS), Kyoto University, Japan

*Corresponding Author:
Kouichi Hasegawa
Senior Lecturer, Institute for Integrated Cell-Material Science (iCeMS)
Kyoto University, Yoshida Honmachi, Sakyo-ku, Kyoto
Kansai region 606-8501
Japan
Tel: +81-75-753-9858
Fax: +81-75-753-9761
E-mail: khasegawa@icems.kyoto-u.ac.jp

Received date: September 29, 2015; Accepted date:September 31, 2015; Published date:October 02, 2015

Visit for more related articles at Insights in Stem Cells

Abstract

Stem cells are a class of undifferentiated biological cells, which has the remarkable potential to develop into many different cell types in the body during early life and growth.

Stem cells are characterized by their ability for self-renewal and the ability to differentiate into specialized cell types.

Editorial

Stem cells are a class of undifferentiated biological cells, which has the remarkable potential to develop into many different cell types in the body during early life and growth.

Stem cells are characterized by their ability for self-renewal and the ability to differentiate into specialized cell types.

Hematopoietic stem cells (HSCs) have been widely used for transplantation therapies and basic study of hematopoiesis and immune mechanisms. Mesenchymal stem cells (MSCs) are also used in many clinical trials. Pluripotent stem cells (PSCs), such as embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs), are most attractive cells because of their unlimited growth and potential to be differentiated into all cell types in body. Several clinical trials of PSC-derived cells are started. Also Patients’-derived iPSCs are used for disease mechanism studies as wells drug screening. Cancer stem cells (CSCs) are also being widely studied for cancer development as well as diagnosis and target therapy. Other stem cells, skin or neural stem cells for example, are also being widely studied. In addition, recently, many stem cells/progenitor cells are being discovered in variety of tissue in human body. Many of these tissues cannot be regenerated in human body. Therefore, it was believed there is no stem/progenitor cell until very recent. Although many of the cells are quiescent and does not self-renew or differentiate in normal condition, these finding opens up for possibility of tissue regeneration in many of human tissue.

Stem cell research is one of the scientific fields can connect basic research and translational application. Stem cell study has great potential for cure many diseases. This is highly beneficial for society and economics. All of the stem cell applications are results of basic researches and technical innovations. Therefore, these studies should be published quickly and distributed to public widely without political biases. In this spirit, we would like to welcome to you a new journal Insight in Stem Cells [1] on top of many other stem cell journals.

Insight in Stem Cells [1] is open access journal, and articles will be spread through social media, such as Twitter, Facebook and Scribd, on top of traditional repositories or indexes. We covers all area of stem cells research, such as Cancer Stem Cells, Stem-cell transplantation, Organ and Organism-Specific stem cells, Stem Cell Biology, Stem cell therapy etc., and all type of manuscripts, including Original Research, Review, Case report, short commentaries, rapid communications, letter to editor, perspectives, opinion, hypothesis etc. Submitted papers will be reviewed in a first track, and accepted articles will be in first track editing process and available online for viewing and downloading.

All copyrights are under creative a common license, which meets NIH public access policy and Welcome Trust open access policy. Among many other stem cell journals, Insight in Stem Cells [1] is unique and new platform for distribute your studies, discovery and opinions rapidly and widely to public. That means Insight in Stem Cells [1] will also support development of stem cell field. We hope this spirit and vision inspire you to submit your manuscript to our Insight in Stem Cells [1].

References